v3.26.3
Stockholder's Equity - Schedule of unvested shares of restricted stock (Details)
9 Months Ended 12 Months Ended
Sep. 30, 2026
installment
$ / shares
shares
Dec. 31, 2023
Dec. 31, 2022
shares
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Performance period   3 years 3 years
Equity instrument activity      
Outstanding, at beginning of period (in shares) 2,508,721    
Granted (in shares) 571,400    
Earned at completion of three-year performance period (in shares) 12,052    
Conversion to common stock (in shares) (6,852)    
Vesting of restricted shares (in shares) (133,666)    
Outstanding, at end of period (in shares) 2,951,655    
Weighted Average Grant Date Fair Value      
Weighted average grant date fair value at beginning of period (in dollars per share) | $ / shares $ 15.07    
Granted (in dollars per share) | $ / shares 18.95    
Earned at completion of three-year performance period (in dollars per share) | $ / shares 19.35    
Conversions to common stock (in dollars per share) | $ / shares 14.66    
Vesting of restricted shares (in dollars per share) | $ / shares 15.75    
Weighted average grant date fair value at end of period (in dollars per share) | $ / shares $ 15.81    
Officers and employees      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Restricted stock withholdings (in shares) 81,009    
Restricted shares withheld (in shares) 52,657    
CEO | LTIP | Operating Partnership Unitholders’ Non-controlling Interests      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Shares issued in period (in shares) 184,877    
President | LTIP | Operating Partnership Unitholders’ Non-controlling Interests      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Shares issued in period (in shares) 91,287    
Director | LTIP | Operating Partnership Unitholders’ Non-controlling Interests      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Award vesting period 3 years    
Shares issued in period (in shares) 34,112    
Certain employees | LTIP | Operating Partnership Unitholders’ Non-controlling Interests      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Shares issued in period (in shares) 92,891    
Consultant | LTIP | Operating Partnership Unitholders’ Non-controlling Interests      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Shares issued in period (in shares) 4,194    
Restricted Shares      
Equity instrument activity      
Outstanding, at beginning of period (in shares) 477,452    
Granted (in shares) 81,674    
Earned at completion of three-year performance period (in shares) 0    
Conversion to common stock (in shares) 0    
Vesting of restricted shares (in shares) (62,797)    
Outstanding, at end of period (in shares) 496,329    
Restricted Shares | Officers and employees      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Number of award vesting installments | installment 3    
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche One      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Award vesting period 3 years    
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche Two      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Award vesting period 5 years    
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche Three      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Award vesting period 8 years    
LTIP Units      
Equity instrument activity      
Outstanding, at beginning of period (in shares) 1,669,217    
Granted (in shares) 407,361    
Earned at completion of three-year performance period (in shares) 0    
Conversion to common stock (in shares) (6,852)    
Vesting of restricted shares (in shares) 0    
Outstanding, at end of period (in shares) 2,069,726    
RSUs      
Equity instrument activity      
Outstanding, at beginning of period (in shares) 362,052    
Granted (in shares) 82,365   47,005
Earned at completion of three-year performance period (in shares) 12,052    
Conversion to common stock (in shares) 0    
Vesting of restricted shares (in shares) (70,869)    
Outstanding, at end of period (in shares) 385,600    
RSUs | Certain officers and employees      
Equity instrument activity      
Granted (in shares) 71,041    
Market-Based RSUs      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Requisite service period 3 years    
Time-Based RSUs | Certain employees      
Equity instrument activity      
Granted (in shares) 11,325    
Performance-Based RSUs      
Stockholder's Equity - Schedule of unvested shares of restricted stock [Line Items]      
Performance period 3 years    
Performance target earned, percentage 123.10%